effects [qlco]
Oral [spco]
transdermal estrogen [horm, phsu, strd]
Low dose [qnco]
therapy [ftcn]
Echocardiography [diap]
Parameters [fndg]
Cardiac function [ortf]
Objective [inpr]
To [qlco]
investigate [ftcn]
effects [qlco]
Transdermal [ftcn]
Compared [acty]
Oral [spco]
Echocardiography [diap]
Parameters [fndg]
Left Ventricle [bpoc]
Systolic [tmco]
Diastolic [clna]
function [phsf]
Design [acty]
prospective [resa]
randomized [resa]
DOUBLE BLIND [resa]
placebo-controlled [resa]
Multicenter Study [resa]
setting [ftcn]
Gynecologic [spco]
cardiology departments [hcro]
Out-patient [podg]
One [qnco]
Two [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
intervention [hlca]
participants [popg]
Received [qlco]
Daily [tmco]
placebo [topp]
N NOS [aapp, imft]
Transdermal [ftcn]
Te [elii, hops]
Group [idcn]
N NOS [aapp, imft]
Oral [spco]
mg% [qnco]
Oe [qnco]
Group [idcn]
N NOS [aapp, imft]
Oral [spco]
mg% [qnco]
Combined [qlco]
Gestodene [phsu, strd]
Oe [qnco]
g% [qnco]
Group [idcn]
N NOS [aapp, imft]
treatment [ftcn]
Cycle [tmco]
Main [qlco]
outcome measure [qnco]
M NOS [aapp, imft]
Mode [ftcn]
Quantitative [qnco]
Echocardiography, Doppler [diap]
measurements [ftcn]
Performed [ftcn]
baseline [bodm]
Result [ftcn]
Compared [acty]
placebo [topp]
Te [elii, hops]
Oe [qnco]
Show [inpr]
statistically significant [qnco]
Left Ventricular Function [ortf]
Oe [qnco]
g% [qnco]
Result [ftcn]
statistically significant [qnco]
Favorable [qlco]
Increase [ftcn]
peak flow [fndg]
Velocity [qnco]
Flow [npop]
Velocity [qnco]
Integral [qnco]
Mean [qnco]
Acceleration [phpr]
Favorable [qlco]
Decrease [qlco]
Observed [ftcn]
Interventricular septum [bpoc]
Thickness [qlco]
Ejection time [orga]
Conclusion [idcn]
Left Ventricular Function [ortf]
Unchanged [fndg]
Oe [qnco]
g% [qnco]
treatment [ftcn]
Show [inpr]
Potential [qlco]
influential [idcn]
Left Ventricular Function [ortf]
Systolic [tmco]
[c] [qnco]
American [popg]
society [orgt]
Reproductive Medicine [bmod]
